Trusopt
| Trusopt | |
|---|---|
| DOSAGE | 1 gtt TID |
| GENERIC | Dorzolamide HCl 2% |
| SIZE | 5mL, 10mL |
| INDICATIONS | Reduction of elevated intraocular pressure (IOP) |
| MECHANISM OF ACTION | Decreases aqueous production |
| MICROBIOLOGY | Inhibition of carbonic anhydrase in the ciliary processes of the eye decreases aqueous humor secretion, presumably by slowing the formation of bicarbonate ions with subsequent reduction in sodium and fluid transport. |
| CONTRAINDICATIONS & WARNINGS | Steven’s Johnson syndrome and sulfonamide hypersensitivity |
| PEDIATRIC USE | Safety and effectiveness of TRUSOPT have been demonstrated in pediatric patients in a 3-month, multicenter, double-masked, active-treatment-controlled trial. |
| PREGNANCY | Pregnancy category C | There are no adequate and well-controlled studies in pregnant women with TRUSOPT |
| NOTE | |